Recombinant UCHL1 抗体 (full length)
Our Local Distributor
北京 101111
Quick Overview for Recombinant UCHL1 抗体 (full length) (ABIN7879275)
抗原
See all UCHL1 抗体抗体类型
适用
宿主
克隆类型
标记
应用范围
质量等级
克隆位点
-
-
抗原表位
- full length
-
原理
- Recombinant PGP9.5 Antibody / UchL1 (azide and preservative free)
-
纯化方法
- Protein G affinity chromatography
-
免疫原
- Recombinant full-length human protein was used as the immunogen for the recombinant PGP9.5 antibody.
-
亚型
- IgG2a, kappa
-
-
-
-
应用备注
- Optimal dilution of the recombinant PGP9.5 antibody should be determined by the researcher.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 mg/mL
-
缓冲液
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
储存液
- Azide free
-
储存条件
- 4 °C,-20 °C
-
储存方法
- Store the recombinant PGP9.5 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
-
-
- UCHL1 (Ubiquitin Carboxyl-terminal Esterase L1 (Ubiquitin Thiolesterase) (UCHL1))
-
别名
- PGP9.5
-
背景
- This MAb reacts with a protein of 20-30 kDa, identified as PGP9.5, also known as ubiquitin carboxyl-terminal hydrolase-1 (UchL1). Initially, PGP9.5 expression in normal tissues was reported in neurons and neuroendocrine cells but later it was found in distal renal tubular epithelium, spermatogonia, Leydig cells, oocytes, melanocytes, prostatic secretory epithelium, ejaculatory duct cells, epididymis, mammary epithelial cells, Merkel cells, and dermal fibroblasts. Furthermore, immunostaining for PGP9.5 has been shown in a wide variety of mesenchymal neoplasms as well. A mutation in PGP9.5 gene is believed to cause a form of Parkinsons disease.
-
UniProt
- P09936
-
途径
- Feeding Behaviour
抗原
-